エピレプシー患者の遺伝系

Impact of generic substitution of anticonvulsants on the treatment of epilepsy.

CNS drugs·2013

α-adrenoceptor blocking drugs, pressor responses to noradrenaline, and the ankle jerk in man.

British journal of clinical pharmacology·2012

The influence of elevated plasma hydrocortisone concentrations on antipyrine metabolism in man.

British journal of clinical pharmacology·2012

Inhibition of phenytoin metabolism by sulthiame in epileptic patients.

British journal of clinical pharmacology·2012

The effects of salbutamol and terbutaline on physiological tremor, bronchial tone and heart rate.

British journal of clinical pharmacology·2012

Preliminary assessment of RX 72601, a new anticholinesterase in man: reversal of competitive neuromuscular blockade.

British journal of clinical pharmacology·2012

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Genomic landscape of Mexican patients with maturity onset diabetes of the young: beyond mutations in MODY-known genes.

Frontiers in endocrinology·2026

Linking SIRT1 gene variation and protein levels to the pathophysiology of type 2 diabetes.

Molecular biology research communications·2026

Pharmacogenetic analyses in people with dementia in Northeast Germany.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026

Research progress on targeted regulatory proteins in the prevention and treatment of atherosclerosis.

Frontiers in immunology·2026

Retraction Note: Micropropagation and assessment of genetic fidelity of Dendrocalamus strictus (Roxb.) nees using RAPD and ISSR markers.

3 Biotech·2026

Distribution of ST116 carbapenem-resistant Citrobacter freundii in public genomes and characterization of a triple-carbapenemase-producing strain.

Frontiers in cellular and infection microbiology·2026

関連する実験動画

エピレプシー患者の遺伝系

関連する概念動画

Impact of generic substitution of anticonvulsants on the treatment of epilepsy.

α-adrenoceptor blocking drugs, pressor responses to noradrenaline, and the ankle jerk in man.

The influence of elevated plasma hydrocortisone concentrations on antipyrine metabolism in man.

Inhibition of phenytoin metabolism by sulthiame in epileptic patients.

The effects of salbutamol and terbutaline on physiological tremor, bronchial tone and heart rate.

Preliminary assessment of RX 72601, a new anticholinesterase in man: reversal of competitive neuromuscular blockade.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Genomic landscape of Mexican patients with maturity onset diabetes of the young: beyond mutations in MODY-known genes.

Linking SIRT1 gene variation and protein levels to the pathophysiology of type 2 diabetes.

Pharmacogenetic analyses in people with dementia in Northeast Germany.

Research progress on targeted regulatory proteins in the prevention and treatment of atherosclerosis.

Retraction Note: Micropropagation and assessment of genetic fidelity of Dendrocalamus strictus (Roxb.) nees using RAPD and ISSR markers.

Distribution of ST116 carbapenem-resistant Citrobacter freundii in public genomes and characterization of a triple-carbapenemase-producing strain.

関連する実験動画

エピレプシー患者の遺伝系

関連する概念動画

関連記事